Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07800546

Intrarenal Pressure Monitoring During Pediatric Percutaneous Nephrolithotomy, and Its Impact on Post Operative Infectious Complications.

Monitoring of intrarenal pressure during pediatric percutaneous nephrolithotomy and its impact on post operative infectious complications.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age < 18 years Undergoing PCNL for renal calculi

Exclusion criteria

  • Active untreated urinary infection High grade vesicoureteric reflux ( grade IV _V) Immunocompromised patients

Treatment and study plan

Intrarenal pressure

Diagnostic Test

Monitoring of intrarenal pressure during pediatric percutaneous nephrolithotomy

Primary outcomes

  1. Infectious complications

    Time frame: 72 hours post operative

    Post operative infectious complications after pediatric percutaneous nephrolithotomy

  2. Post operative infectious complications

    Time frame: 2 years

    Monitoring of intrarenal pressure during pediatric percutaneous nephrolithotomy and its impact on post operative infectious complications

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Sep 2, 2026
Registry last updated
Sep 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.